CXMT STAR Market Debut: The 6.7% Float Behind the 500% Pop
ChangXin Memory Technologies opened at 49.50 yuan against an IPO price of 8.66 and closed the morning session up 531%, carrying a market capitalization near 3.66 trillion yuan and making it the most valuable company listed on the mainland. The headline number is 500%. The number that explains it is 6.73%.
That is the share of post-IPO capital that was unrestricted and tradable on day one — roughly 4.5 billion shares out of a base that runs to nearly 67 billion. Institutional demand for the allocation exceeded 500 times the shares offered; retail subscription ran better than 200 to one. A first trade that added some 2.7 trillion yuan of implied value did so against a sliver of float, before a single wafer of incremental capacity existed or a single customer qualification changed. Price discovery on 6.73% of a company is not price discovery. It is an auction for scarcity, and it resolves when the scarcity does.
The mechanical effects were visible before the listing. The STAR 50 index fell approximately 20% from its July 1 peak as investors liquidated existing positions to fund subscriptions, cash frozen in the standard Chinese allocation process. That drawdown was liquidity, not a verdict on Chinese technology equities, and the mechanism reverses on its own. The interesting question is what happens to the 3.66 trillion yuan valuation on January 27, 2027, when the first lock-up expires and tradable supply expands. Pre-IPO holders sit under 12- and 36-month restrictions. Share supply, not sentiment, is the clearest identifiable risk to the price.
Strip out the debut mechanics and what remains is a genuinely significant operating statement. First-quarter revenue reached 50.8 billion yuan, up 719% year over year, with profit attributable to shareholders up better than 1,688%. The company guides first-half revenue to 110 to 120 billion yuan and attributable net profit to 50 to 57 billion. Those numbers are not primarily a statement about Chinese industrial policy. They are a statement about DRAM pricing, and they arrive from a producer with no exposure to the high-bandwidth memory contracts that Western investors have used to explain the cycle. Commodity DRAM, sold into a domestic market, at prices reportedly above Samsung’s, produced that swing. The memory cycle is broader and more durable than the HBM narrative alone accounts for, and CXMT’s income statement is the cleanest available proof of it.
The moat is the part the valuation is least able to defend. CXMT held roughly 7.67% of the global DRAM market on 2025 fourth-quarter sales and controls something near 11% of global wafer capacity, targeting approximately 15% by 2028. That is scale — enough to move conventional memory pricing. It is not process leadership. The company approximates advanced feature sizes using deep-ultraviolet multi-patterning, self-aligned double and quadruple exposure, where EUV-equipped competitors achieve the same geometry in a single pass. Every additional patterning step adds process complexity and overlay error, and both land in cost per bit. That penalty is structural until the equipment access changes, and the equipment access is precisely what export controls are designed to prevent from changing. The 57.9 billion yuan raised — up to 66.6 billion with the overallotment, 7.5 billion of it earmarked for upgrading memory wafer production lines — buys capacity and domestic tooling. It does not buy the lithography that closes the gap.
The generational position tells the same story. Samsung, SK Hynix and Micron are producing or shipping HBM4. CXMT is targeting HBM3, without large-scale commercial shipments to demonstrate. The gap in AI memory is not one product cycle; it is a cycle plus the toolset needed to run it. What CXMT has instead is state backing, a captive home market that wants exactly what it sells, and now nearly nine billion dollars of fresh capital. Reports that Apple has begun testing its DRAM for devices sold in China matter more than any capacity target, because qualification by a Western OEM is the only evidence that the product competes rather than merely exists.
For US-listed memory names the read-through splits by segment and by horizon. The listing changes nothing about near-term supply and demand — capacity does not arrive because an IPO priced. Over two to three years, a state-backed fourth player expanding aggressively in commodity DRAM is a real margin risk to the low end of Micron’s mix, and that risk is not currently priced anywhere in the memory complex. Against it runs a second-order effect that cuts the other way: pressure on conventional DRAM pricing accelerates the incumbents’ rotation of wafer capacity toward high-bandwidth memory, which is where the pricing power and the packaging intensity already sit. Competition at the commodity end pushes the big three further into the segment CXMT cannot reach. Advanced packaging and hybrid bonding equipment suppliers are, on that logic, beneficiaries of Chinese commodity expansion rather than victims of it — and none of the 57.9 billion yuan is available to buy their tools regardless.
On the multiple, the opening price implies roughly 29 to 33 times annualized 2026 earnings if the guided first half repeats in the second. That is not an obviously deranged number for a company compounding at these rates, which is what makes the setup treacherous rather than simply absurd. The entire valuation rests on the assumption that DRAM pricing holds through 2027. If it does, the multiple is defensible and the day-one pop merely front-runs it. If the cycle turns, an 11%-share producer with a cost-per-bit disadvantage and 60 billion yuan of expansion capital is the highest-beta expression of the downturn available anywhere in memory.
Foreign investors mostly cannot act on either view. CXMT was not included on the Northbound Stock Connect eligibility list updated on July 24, leaving access dependent on institutional A-share routes. The practical exposure available to most portfolios is the read-through, not the security.
The pop is noise. The disclosure to watch is wafer starts — the capacity numbers CXMT publishes over the next several quarters, against the 2028 targets. A hot listing fades inside a month. Committed capacity lives in memory pricing for years.